News by community
02.10.2019 ND-BioSciences awarded a grant from The Michael J. Fox Foundation to help advance the foundation’s α-Synuclein biomarkers discovery and validation programs
ND BioSciences, a Swiss-based biotechnology company that was founded with the mission of accelerating the development of early diagnostics and therapies for neurodegenerative diseases, today announced that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a grant of for its Protein Science and Discovery program.